MoonLake Immunotherapeutics (MLTX)

45.56 -1.20 (-2.57%) USD  |  NASDAQ  |  Nov 04, 13:24
More

MoonLake Immunotherapeutics EV to Revenues

EV to Revenues Chart

View EV to Revenues for MLTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Revenues Data

View and export this data back to . Upgrade now.
Date Value

EV to Revenues Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

Novartis AG Upgrade
AC Immune SA --
CRISPR Therapeutics AG --
Addex Therapeutics Ltd Upgrade
NLS Pharmaceutics Ltd --

EV to Revenues Related Metrics

EV to Free Cash Flow Upgrade